We are proud to announce the launch of our high-quality Enoxaparin Sodium Injection, a trusted low molecular weight heparin designed for effective antithrombotic therapy. This medication is widely indicated for the prophylaxis of deep vein thrombosis (DVT), particularly in patients undergoing orthopedic or general abdominal surgeries. It is also utilized in the treatment of established DVT, with or without pulmonary embolism, and for managing unstable angina and non-Q-wave myocardial infarction in conjunction with aspirin.
Our Enoxaparin Sodium Injection is available in two precise specifications to meet diverse clinical needs: 0.4ml:4000 IU and 0.6ml:6000 IU. Each package contains 2 pre-filled syringes, ensuring convenience, accurate dosing, and enhanced safety for healthcare professionals and patients.
By offering this essential medication, we remain committed to providing reliable, high-standard pharmaceutical solutions that support cardiovascular health and improve patient outcomes. For more detailed prescribing information, please consult the full product label.
